nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—CA4—Alzheimer's disease	0.738	1	CbGaD
Metolazone—CA5A—Reversible hydration of carbon dioxide—CA4—Alzheimer's disease	0.0106	0.147	CbGpPWpGaD
Metolazone—CA5B—Reversible hydration of carbon dioxide—CA4—Alzheimer's disease	0.00991	0.137	CbGpPWpGaD
Metolazone—CA7—Reversible hydration of carbon dioxide—CA4—Alzheimer's disease	0.00991	0.137	CbGpPWpGaD
Metolazone—CA12—Reversible hydration of carbon dioxide—CA4—Alzheimer's disease	0.00918	0.127	CbGpPWpGaD
Metolazone—CA9—Reversible hydration of carbon dioxide—CA4—Alzheimer's disease	0.00592	0.082	CbGpPWpGaD
Metolazone—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC24A4—Alzheimer's disease	0.00191	0.0264	CbGpPWpGaD
Metolazone—Methyclothiazide—CA4—Alzheimer's disease	0.00144	0.212	CrCbGaD
Metolazone—Benzthiazide—CA4—Alzheimer's disease	0.00139	0.205	CrCbGaD
Metolazone—Indapamide—CA4—Alzheimer's disease	0.00138	0.204	CrCbGaD
Metolazone—Chlorothiazide—CA4—Alzheimer's disease	0.00138	0.204	CrCbGaD
Metolazone—Blood urea increased—Memantine—Alzheimer's disease	0.00121	0.00671	CcSEcCtD
Metolazone—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.00121	0.00669	CcSEcCtD
Metolazone—Neuropathy—Memantine—Alzheimer's disease	0.0012	0.00667	CcSEcCtD
Metolazone—Hypokalaemia—Galantamine—Alzheimer's disease	0.0012	0.00667	CcSEcCtD
Metolazone—Skin exfoliation—Rivastigmine—Alzheimer's disease	0.0012	0.00664	CcSEcCtD
Metolazone—Chlorthalidone—CA4—Alzheimer's disease	0.00119	0.175	CrCbGaD
Metolazone—Neuropathy—Rivastigmine—Alzheimer's disease	0.00118	0.00653	CcSEcCtD
Metolazone—Abdominal discomfort—Galantamine—Alzheimer's disease	0.00109	0.00607	CcSEcCtD
Metolazone—Vascular purpura—Memantine—Alzheimer's disease	0.00104	0.00577	CcSEcCtD
Metolazone—Hyperglycaemia—Galantamine—Alzheimer's disease	0.00103	0.00571	CcSEcCtD
Metolazone—Hyponatraemia—Donepezil—Alzheimer's disease	0.00103	0.0057	CcSEcCtD
Metolazone—Vascular purpura—Rivastigmine—Alzheimer's disease	0.00102	0.00564	CcSEcCtD
Metolazone—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.000998	0.00554	CcSEcCtD
Metolazone—Purpura—Memantine—Alzheimer's disease	0.000964	0.00535	CcSEcCtD
Metolazone—Epistaxis—Galantamine—Alzheimer's disease	0.00096	0.00533	CcSEcCtD
Metolazone—Lethargy—Memantine—Alzheimer's disease	0.000949	0.00526	CcSEcCtD
Metolazone—Purpura—Rivastigmine—Alzheimer's disease	0.000943	0.00524	CcSEcCtD
Metolazone—Dry skin—Donepezil—Alzheimer's disease	0.000938	0.00521	CcSEcCtD
Metolazone—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000935	0.00519	CcSEcCtD
Metolazone—Hyponatraemia—Memantine—Alzheimer's disease	0.000933	0.00518	CcSEcCtD
Metolazone—Hypokalaemia—Donepezil—Alzheimer's disease	0.000932	0.00517	CcSEcCtD
Metolazone—Cramp muscle—Donepezil—Alzheimer's disease	0.000922	0.00512	CcSEcCtD
Metolazone—Hepatitis—Galantamine—Alzheimer's disease	0.000914	0.00507	CcSEcCtD
Metolazone—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.000913	0.00507	CcSEcCtD
Metolazone—Abdominal distension—Donepezil—Alzheimer's disease	0.000891	0.00494	CcSEcCtD
Metolazone—Pancreatitis—Donepezil—Alzheimer's disease	0.000867	0.00481	CcSEcCtD
Metolazone—SLC12A3—SLC-mediated transmembrane transport—SLC24A4—Alzheimer's disease	0.000852	0.0118	CbGpPWpGaD
Metolazone—Tinnitus—Galantamine—Alzheimer's disease	0.000852	0.00473	CcSEcCtD
Metolazone—Dry skin—Memantine—Alzheimer's disease	0.000852	0.00473	CcSEcCtD
Metolazone—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000849	0.00471	CcSEcCtD
Metolazone—Abdominal discomfort—Donepezil—Alzheimer's disease	0.000848	0.00471	CcSEcCtD
Metolazone—Hypokalaemia—Memantine—Alzheimer's disease	0.000846	0.00469	CcSEcCtD
Metolazone—Dry skin—Rivastigmine—Alzheimer's disease	0.000833	0.00462	CcSEcCtD
Metolazone—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000831	0.00461	CcSEcCtD
Metolazone—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.000828	0.00459	CcSEcCtD
Metolazone—Cramp muscle—Rivastigmine—Alzheimer's disease	0.000819	0.00454	CcSEcCtD
Metolazone—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000798	0.00443	CcSEcCtD
Metolazone—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—Alzheimer's disease	0.000798	0.0111	CbGpPWpGaD
Metolazone—Pancreatitis—Memantine—Alzheimer's disease	0.000788	0.00437	CcSEcCtD
Metolazone—Flatulence—Galantamine—Alzheimer's disease	0.000784	0.00435	CcSEcCtD
Metolazone—Tension—Galantamine—Alzheimer's disease	0.000781	0.00433	CcSEcCtD
Metolazone—Dysgeusia—Galantamine—Alzheimer's disease	0.000779	0.00432	CcSEcCtD
Metolazone—Nervousness—Galantamine—Alzheimer's disease	0.000773	0.00429	CcSEcCtD
Metolazone—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000771	0.00428	CcSEcCtD
Metolazone—Back pain—Galantamine—Alzheimer's disease	0.000769	0.00427	CcSEcCtD
Metolazone—Muscle spasms—Galantamine—Alzheimer's disease	0.000765	0.00424	CcSEcCtD
Metolazone—Vision blurred—Galantamine—Alzheimer's disease	0.00075	0.00416	CcSEcCtD
Metolazone—Epistaxis—Donepezil—Alzheimer's disease	0.000744	0.00413	CcSEcCtD
Metolazone—Erectile dysfunction—Memantine—Alzheimer's disease	0.00074	0.00411	CcSEcCtD
Metolazone—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000738	0.0041	CcSEcCtD
Metolazone—Anaemia—Galantamine—Alzheimer's disease	0.000735	0.00408	CcSEcCtD
Metolazone—Agitation—Galantamine—Alzheimer's disease	0.000731	0.00406	CcSEcCtD
Metolazone—Hyperglycaemia—Memantine—Alzheimer's disease	0.000725	0.00402	CcSEcCtD
Metolazone—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000724	0.00402	CcSEcCtD
Metolazone—Malaise—Galantamine—Alzheimer's disease	0.000717	0.00398	CcSEcCtD
Metolazone—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000717	0.00398	CcSEcCtD
Metolazone—Vertigo—Galantamine—Alzheimer's disease	0.000715	0.00397	CcSEcCtD
Metolazone—Syncope—Galantamine—Alzheimer's disease	0.000713	0.00396	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00071	0.00394	CcSEcCtD
Metolazone—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000709	0.00393	CcSEcCtD
Metolazone—Hepatitis—Donepezil—Alzheimer's disease	0.000708	0.00393	CcSEcCtD
Metolazone—Palpitations—Galantamine—Alzheimer's disease	0.000703	0.0039	CcSEcCtD
Metolazone—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000702	0.0039	CcSEcCtD
Metolazone—Drowsiness—Rivastigmine—Alzheimer's disease	0.000701	0.00389	CcSEcCtD
Metolazone—Loss of consciousness—Galantamine—Alzheimer's disease	0.000699	0.00388	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000695	0.00386	CcSEcCtD
Metolazone—Cough—Galantamine—Alzheimer's disease	0.000694	0.00385	CcSEcCtD
Metolazone—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000687	0.00381	CcSEcCtD
Metolazone—Hypertension—Galantamine—Alzheimer's disease	0.000687	0.00381	CcSEcCtD
Metolazone—Arthralgia—Galantamine—Alzheimer's disease	0.000677	0.00376	CcSEcCtD
Metolazone—Chest pain—Galantamine—Alzheimer's disease	0.000677	0.00376	CcSEcCtD
Metolazone—Epistaxis—Memantine—Alzheimer's disease	0.000676	0.00375	CcSEcCtD
Metolazone—Anxiety—Galantamine—Alzheimer's disease	0.000675	0.00375	CcSEcCtD
Metolazone—Discomfort—Galantamine—Alzheimer's disease	0.000669	0.00371	CcSEcCtD
Metolazone—Agranulocytosis—Memantine—Alzheimer's disease	0.000668	0.00371	CcSEcCtD
Metolazone—Dry mouth—Galantamine—Alzheimer's disease	0.000662	0.00368	CcSEcCtD
Metolazone—Epistaxis—Rivastigmine—Alzheimer's disease	0.000661	0.00367	CcSEcCtD
Metolazone—Tinnitus—Donepezil—Alzheimer's disease	0.00066	0.00366	CcSEcCtD
Metolazone—CA9—HIF-1-alpha transcription factor network—CP—Alzheimer's disease	0.000659	0.00913	CbGpPWpGaD
Metolazone—Hepatitis—Memantine—Alzheimer's disease	0.000643	0.00357	CcSEcCtD
Metolazone—Shock—Galantamine—Alzheimer's disease	0.000639	0.00354	CcSEcCtD
Metolazone—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000636	0.00353	CcSEcCtD
Metolazone—Chills—Donepezil—Alzheimer's disease	0.000635	0.00353	CcSEcCtD
Metolazone—Hepatitis—Rivastigmine—Alzheimer's disease	0.000629	0.00349	CcSEcCtD
Metolazone—Anorexia—Galantamine—Alzheimer's disease	0.000619	0.00343	CcSEcCtD
Metolazone—Erythema multiforme—Memantine—Alzheimer's disease	0.000608	0.00337	CcSEcCtD
Metolazone—Flatulence—Donepezil—Alzheimer's disease	0.000608	0.00337	CcSEcCtD
Metolazone—Tension—Donepezil—Alzheimer's disease	0.000605	0.00336	CcSEcCtD
Metolazone—Dysgeusia—Donepezil—Alzheimer's disease	0.000604	0.00335	CcSEcCtD
Metolazone—Tinnitus—Memantine—Alzheimer's disease	0.0006	0.00333	CcSEcCtD
Metolazone—Nervousness—Donepezil—Alzheimer's disease	0.000599	0.00332	CcSEcCtD
Metolazone—Back pain—Donepezil—Alzheimer's disease	0.000596	0.00331	CcSEcCtD
Metolazone—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000595	0.0033	CcSEcCtD
Metolazone—Muscle spasms—Donepezil—Alzheimer's disease	0.000593	0.00329	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000592	0.00328	CcSEcCtD
Metolazone—SLC12A3—SLC-mediated transmembrane transport—SLC30A6—Alzheimer's disease	0.000591	0.00819	CbGpPWpGaD
Metolazone—Insomnia—Galantamine—Alzheimer's disease	0.000587	0.00326	CcSEcCtD
Metolazone—Tinnitus—Rivastigmine—Alzheimer's disease	0.000587	0.00325	CcSEcCtD
Metolazone—Paraesthesia—Galantamine—Alzheimer's disease	0.000583	0.00323	CcSEcCtD
Metolazone—Vision blurred—Donepezil—Alzheimer's disease	0.000581	0.00322	CcSEcCtD
Metolazone—Somnolence—Galantamine—Alzheimer's disease	0.000577	0.0032	CcSEcCtD
Metolazone—Chills—Memantine—Alzheimer's disease	0.000577	0.0032	CcSEcCtD
Metolazone—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000572	0.00317	CcSEcCtD
Metolazone—Dyspepsia—Galantamine—Alzheimer's disease	0.000572	0.00317	CcSEcCtD
Metolazone—Anaemia—Donepezil—Alzheimer's disease	0.00057	0.00316	CcSEcCtD
Metolazone—Agitation—Donepezil—Alzheimer's disease	0.000567	0.00314	CcSEcCtD
Metolazone—Chills—Rivastigmine—Alzheimer's disease	0.000564	0.00313	CcSEcCtD
Metolazone—Decreased appetite—Galantamine—Alzheimer's disease	0.000564	0.00313	CcSEcCtD
Metolazone—CA9—HIF-1-alpha transcription factor network—TF—Alzheimer's disease	0.00056	0.00776	CbGpPWpGaD
Metolazone—Fatigue—Galantamine—Alzheimer's disease	0.00056	0.00311	CcSEcCtD
Metolazone—Malaise—Donepezil—Alzheimer's disease	0.000556	0.00308	CcSEcCtD
Metolazone—Constipation—Galantamine—Alzheimer's disease	0.000555	0.00308	CcSEcCtD
Metolazone—Vertigo—Donepezil—Alzheimer's disease	0.000554	0.00307	CcSEcCtD
Metolazone—Syncope—Donepezil—Alzheimer's disease	0.000553	0.00307	CcSEcCtD
Metolazone—Flatulence—Memantine—Alzheimer's disease	0.000552	0.00306	CcSEcCtD
Metolazone—Tension—Memantine—Alzheimer's disease	0.000549	0.00305	CcSEcCtD
Metolazone—Dysgeusia—Memantine—Alzheimer's disease	0.000548	0.00304	CcSEcCtD
Metolazone—Nervousness—Memantine—Alzheimer's disease	0.000544	0.00302	CcSEcCtD
Metolazone—Loss of consciousness—Donepezil—Alzheimer's disease	0.000542	0.00301	CcSEcCtD
Metolazone—Back pain—Memantine—Alzheimer's disease	0.000541	0.003	CcSEcCtD
Metolazone—Flatulence—Rivastigmine—Alzheimer's disease	0.00054	0.00299	CcSEcCtD
Metolazone—Cough—Donepezil—Alzheimer's disease	0.000538	0.00299	CcSEcCtD
Metolazone—Tension—Rivastigmine—Alzheimer's disease	0.000537	0.00298	CcSEcCtD
Metolazone—CA9—HIF-1-alpha transcription factor network—ENO1—Alzheimer's disease	0.000537	0.00744	CbGpPWpGaD
Metolazone—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000536	0.00298	CcSEcCtD
Metolazone—Feeling abnormal—Galantamine—Alzheimer's disease	0.000535	0.00297	CcSEcCtD
Metolazone—Hypertension—Donepezil—Alzheimer's disease	0.000532	0.00295	CcSEcCtD
Metolazone—Nervousness—Rivastigmine—Alzheimer's disease	0.000532	0.00295	CcSEcCtD
Metolazone—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000531	0.00295	CcSEcCtD
Metolazone—Back pain—Rivastigmine—Alzheimer's disease	0.00053	0.00294	CcSEcCtD
Metolazone—Vision blurred—Memantine—Alzheimer's disease	0.000528	0.00293	CcSEcCtD
Metolazone—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000526	0.00292	CcSEcCtD
Metolazone—Arthralgia—Donepezil—Alzheimer's disease	0.000525	0.00291	CcSEcCtD
Metolazone—Chest pain—Donepezil—Alzheimer's disease	0.000525	0.00291	CcSEcCtD
Metolazone—Anxiety—Donepezil—Alzheimer's disease	0.000523	0.0029	CcSEcCtD
Metolazone—Ill-defined disorder—Memantine—Alzheimer's disease	0.000519	0.00288	CcSEcCtD
Metolazone—Discomfort—Donepezil—Alzheimer's disease	0.000519	0.00288	CcSEcCtD
Metolazone—Anaemia—Memantine—Alzheimer's disease	0.000517	0.00287	CcSEcCtD
Metolazone—Vision blurred—Rivastigmine—Alzheimer's disease	0.000516	0.00286	CcSEcCtD
Metolazone—Agitation—Memantine—Alzheimer's disease	0.000514	0.00285	CcSEcCtD
Metolazone—Dry mouth—Donepezil—Alzheimer's disease	0.000513	0.00285	CcSEcCtD
Metolazone—Abdominal pain—Galantamine—Alzheimer's disease	0.000513	0.00285	CcSEcCtD
Metolazone—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000508	0.00282	CcSEcCtD
Metolazone—Anaemia—Rivastigmine—Alzheimer's disease	0.000506	0.00281	CcSEcCtD
Metolazone—Malaise—Memantine—Alzheimer's disease	0.000505	0.0028	CcSEcCtD
Metolazone—Agitation—Rivastigmine—Alzheimer's disease	0.000503	0.00279	CcSEcCtD
Metolazone—Vertigo—Memantine—Alzheimer's disease	0.000503	0.00279	CcSEcCtD
Metolazone—SLC12A3—SLC-mediated transmembrane transport—APOD—Alzheimer's disease	0.000502	0.00697	CbGpPWpGaD
Metolazone—Syncope—Memantine—Alzheimer's disease	0.000502	0.00279	CcSEcCtD
Metolazone—Leukopenia—Memantine—Alzheimer's disease	0.000501	0.00278	CcSEcCtD
Metolazone—Shock—Donepezil—Alzheimer's disease	0.000495	0.00275	CcSEcCtD
Metolazone—Palpitations—Memantine—Alzheimer's disease	0.000495	0.00274	CcSEcCtD
Metolazone—Malaise—Rivastigmine—Alzheimer's disease	0.000494	0.00274	CcSEcCtD
Metolazone—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000493	0.00273	CcSEcCtD
Metolazone—Vertigo—Rivastigmine—Alzheimer's disease	0.000492	0.00273	CcSEcCtD
Metolazone—Loss of consciousness—Memantine—Alzheimer's disease	0.000492	0.00273	CcSEcCtD
Metolazone—Syncope—Rivastigmine—Alzheimer's disease	0.000491	0.00273	CcSEcCtD
Metolazone—Cough—Memantine—Alzheimer's disease	0.000488	0.00271	CcSEcCtD
Metolazone—SLC12A3—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.000486	0.00674	CbGpPWpGaD
Metolazone—Palpitations—Rivastigmine—Alzheimer's disease	0.000484	0.00269	CcSEcCtD
Metolazone—Hypertension—Memantine—Alzheimer's disease	0.000483	0.00268	CcSEcCtD
Metolazone—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000481	0.00267	CcSEcCtD
Metolazone—Anorexia—Donepezil—Alzheimer's disease	0.00048	0.00266	CcSEcCtD
Metolazone—Hypersensitivity—Galantamine—Alzheimer's disease	0.000478	0.00265	CcSEcCtD
Metolazone—Cough—Rivastigmine—Alzheimer's disease	0.000478	0.00265	CcSEcCtD
Metolazone—Chest pain—Memantine—Alzheimer's disease	0.000477	0.00264	CcSEcCtD
Metolazone—Arthralgia—Memantine—Alzheimer's disease	0.000477	0.00264	CcSEcCtD
Metolazone—Anxiety—Memantine—Alzheimer's disease	0.000475	0.00264	CcSEcCtD
Metolazone—Hypertension—Rivastigmine—Alzheimer's disease	0.000473	0.00262	CcSEcCtD
Metolazone—Discomfort—Memantine—Alzheimer's disease	0.000471	0.00261	CcSEcCtD
Metolazone—Chest pain—Rivastigmine—Alzheimer's disease	0.000466	0.00259	CcSEcCtD
Metolazone—Arthralgia—Rivastigmine—Alzheimer's disease	0.000466	0.00259	CcSEcCtD
Metolazone—Dry mouth—Memantine—Alzheimer's disease	0.000466	0.00259	CcSEcCtD
Metolazone—Asthenia—Galantamine—Alzheimer's disease	0.000466	0.00258	CcSEcCtD
Metolazone—Anxiety—Rivastigmine—Alzheimer's disease	0.000465	0.00258	CcSEcCtD
Metolazone—Discomfort—Rivastigmine—Alzheimer's disease	0.000461	0.00256	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000458	0.00254	CcSEcCtD
Metolazone—Dry mouth—Rivastigmine—Alzheimer's disease	0.000456	0.00253	CcSEcCtD
Metolazone—Insomnia—Donepezil—Alzheimer's disease	0.000455	0.00253	CcSEcCtD
Metolazone—Paraesthesia—Donepezil—Alzheimer's disease	0.000452	0.00251	CcSEcCtD
Metolazone—Shock—Memantine—Alzheimer's disease	0.000449	0.00249	CcSEcCtD
Metolazone—Somnolence—Donepezil—Alzheimer's disease	0.000447	0.00248	CcSEcCtD
Metolazone—Thrombocytopenia—Memantine—Alzheimer's disease	0.000447	0.00248	CcSEcCtD
Metolazone—Diarrhoea—Galantamine—Alzheimer's disease	0.000444	0.00246	CcSEcCtD
Metolazone—Dyspepsia—Donepezil—Alzheimer's disease	0.000443	0.00246	CcSEcCtD
Metolazone—Shock—Rivastigmine—Alzheimer's disease	0.00044	0.00244	CcSEcCtD
Metolazone—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000438	0.00243	CcSEcCtD
Metolazone—Decreased appetite—Donepezil—Alzheimer's disease	0.000437	0.00243	CcSEcCtD
Metolazone—Anorexia—Memantine—Alzheimer's disease	0.000435	0.00242	CcSEcCtD
Metolazone—Fatigue—Donepezil—Alzheimer's disease	0.000434	0.00241	CcSEcCtD
Metolazone—SLC12A3—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000433	0.00601	CbGpPWpGaD
Metolazone—Pain—Donepezil—Alzheimer's disease	0.00043	0.00239	CcSEcCtD
Metolazone—Constipation—Donepezil—Alzheimer's disease	0.00043	0.00239	CcSEcCtD
Metolazone—Dizziness—Galantamine—Alzheimer's disease	0.000429	0.00238	CcSEcCtD
Metolazone—Anorexia—Rivastigmine—Alzheimer's disease	0.000426	0.00236	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000416	0.00231	CcSEcCtD
Metolazone—Feeling abnormal—Donepezil—Alzheimer's disease	0.000415	0.0023	CcSEcCtD
Metolazone—Insomnia—Memantine—Alzheimer's disease	0.000413	0.00229	CcSEcCtD
Metolazone—Vomiting—Galantamine—Alzheimer's disease	0.000413	0.00229	CcSEcCtD
Metolazone—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000411	0.00228	CcSEcCtD
Metolazone—Paraesthesia—Memantine—Alzheimer's disease	0.00041	0.00228	CcSEcCtD
Metolazone—Rash—Galantamine—Alzheimer's disease	0.000409	0.00227	CcSEcCtD
Metolazone—Dermatitis—Galantamine—Alzheimer's disease	0.000409	0.00227	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000407	0.00226	CcSEcCtD
Metolazone—Headache—Galantamine—Alzheimer's disease	0.000407	0.00226	CcSEcCtD
Metolazone—Somnolence—Memantine—Alzheimer's disease	0.000406	0.00225	CcSEcCtD
Metolazone—Insomnia—Rivastigmine—Alzheimer's disease	0.000404	0.00224	CcSEcCtD
Metolazone—Dyspepsia—Memantine—Alzheimer's disease	0.000402	0.00223	CcSEcCtD
Metolazone—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000401	0.00223	CcSEcCtD
Metolazone—Urticaria—Donepezil—Alzheimer's disease	0.0004	0.00222	CcSEcCtD
Metolazone—Abdominal pain—Donepezil—Alzheimer's disease	0.000398	0.00221	CcSEcCtD
Metolazone—Somnolence—Rivastigmine—Alzheimer's disease	0.000397	0.0022	CcSEcCtD
Metolazone—Decreased appetite—Memantine—Alzheimer's disease	0.000397	0.0022	CcSEcCtD
Metolazone—Fatigue—Memantine—Alzheimer's disease	0.000394	0.00219	CcSEcCtD
Metolazone—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000393	0.00218	CcSEcCtD
Metolazone—CA9—HIF-1-alpha transcription factor network—HMOX1—Alzheimer's disease	0.000392	0.00543	CbGpPWpGaD
Metolazone—Constipation—Memantine—Alzheimer's disease	0.000391	0.00217	CcSEcCtD
Metolazone—Pain—Memantine—Alzheimer's disease	0.000391	0.00217	CcSEcCtD
Metolazone—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000389	0.00216	CcSEcCtD
Metolazone—Nausea—Galantamine—Alzheimer's disease	0.000386	0.00214	CcSEcCtD
Metolazone—Fatigue—Rivastigmine—Alzheimer's disease	0.000385	0.00214	CcSEcCtD
Metolazone—Pain—Rivastigmine—Alzheimer's disease	0.000382	0.00212	CcSEcCtD
Metolazone—Constipation—Rivastigmine—Alzheimer's disease	0.000382	0.00212	CcSEcCtD
Metolazone—Feeling abnormal—Memantine—Alzheimer's disease	0.000376	0.00209	CcSEcCtD
Metolazone—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000374	0.00207	CcSEcCtD
Metolazone—Hypersensitivity—Donepezil—Alzheimer's disease	0.000371	0.00206	CcSEcCtD
Metolazone—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000368	0.00204	CcSEcCtD
Metolazone—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000365	0.00203	CcSEcCtD
Metolazone—Urticaria—Memantine—Alzheimer's disease	0.000363	0.00201	CcSEcCtD
Metolazone—Abdominal pain—Memantine—Alzheimer's disease	0.000361	0.002	CcSEcCtD
Metolazone—Asthenia—Donepezil—Alzheimer's disease	0.000361	0.002	CcSEcCtD
Metolazone—Pruritus—Donepezil—Alzheimer's disease	0.000356	0.00198	CcSEcCtD
Metolazone—Urticaria—Rivastigmine—Alzheimer's disease	0.000355	0.00197	CcSEcCtD
Metolazone—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000353	0.00196	CcSEcCtD
Metolazone—CA9—Cellular response to hypoxia—VEGFA—Alzheimer's disease	0.000352	0.00489	CbGpPWpGaD
Metolazone—Diarrhoea—Donepezil—Alzheimer's disease	0.000344	0.00191	CcSEcCtD
Metolazone—Hypersensitivity—Memantine—Alzheimer's disease	0.000337	0.00187	CcSEcCtD
Metolazone—Dizziness—Donepezil—Alzheimer's disease	0.000333	0.00185	CcSEcCtD
Metolazone—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000329	0.00183	CcSEcCtD
Metolazone—Asthenia—Memantine—Alzheimer's disease	0.000328	0.00182	CcSEcCtD
Metolazone—Pruritus—Memantine—Alzheimer's disease	0.000323	0.00179	CcSEcCtD
Metolazone—Asthenia—Rivastigmine—Alzheimer's disease	0.000321	0.00178	CcSEcCtD
Metolazone—Vomiting—Donepezil—Alzheimer's disease	0.00032	0.00178	CcSEcCtD
Metolazone—Rash—Donepezil—Alzheimer's disease	0.000317	0.00176	CcSEcCtD
Metolazone—CA12—forebrain—Alzheimer's disease	0.000317	0.108	CbGeAlD
Metolazone—Dermatitis—Donepezil—Alzheimer's disease	0.000317	0.00176	CcSEcCtD
Metolazone—Pruritus—Rivastigmine—Alzheimer's disease	0.000316	0.00175	CcSEcCtD
Metolazone—SLC12A3—SLC-mediated transmembrane transport—CP—Alzheimer's disease	0.000315	0.00437	CbGpPWpGaD
Metolazone—Headache—Donepezil—Alzheimer's disease	0.000315	0.00175	CcSEcCtD
Metolazone—Diarrhoea—Memantine—Alzheimer's disease	0.000313	0.00173	CcSEcCtD
Metolazone—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000306	0.0017	CcSEcCtD
Metolazone—Dizziness—Memantine—Alzheimer's disease	0.000302	0.00168	CcSEcCtD
Metolazone—CA9—HIF-1-alpha transcription factor network—LEP—Alzheimer's disease	0.0003	0.00416	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.0003	0.00416	CbGpPWpGaD
Metolazone—Nausea—Donepezil—Alzheimer's disease	0.000299	0.00166	CcSEcCtD
Metolazone—Dizziness—Rivastigmine—Alzheimer's disease	0.000296	0.00164	CcSEcCtD
Metolazone—CA12—telencephalon—Alzheimer's disease	0.000292	0.0993	CbGeAlD
Metolazone—Vomiting—Memantine—Alzheimer's disease	0.00029	0.00161	CcSEcCtD
Metolazone—Rash—Memantine—Alzheimer's disease	0.000288	0.0016	CcSEcCtD
Metolazone—Dermatitis—Memantine—Alzheimer's disease	0.000288	0.0016	CcSEcCtD
Metolazone—Headache—Memantine—Alzheimer's disease	0.000286	0.00159	CcSEcCtD
Metolazone—Vomiting—Rivastigmine—Alzheimer's disease	0.000284	0.00158	CcSEcCtD
Metolazone—Rash—Rivastigmine—Alzheimer's disease	0.000282	0.00156	CcSEcCtD
Metolazone—Dermatitis—Rivastigmine—Alzheimer's disease	0.000282	0.00156	CcSEcCtD
Metolazone—Headache—Rivastigmine—Alzheimer's disease	0.00028	0.00155	CcSEcCtD
Metolazone—CA9—HIF-1-alpha transcription factor network—NOS2—Alzheimer's disease	0.00028	0.00388	CbGpPWpGaD
Metolazone—Nausea—Memantine—Alzheimer's disease	0.000271	0.00151	CcSEcCtD
Metolazone—Nausea—Rivastigmine—Alzheimer's disease	0.000265	0.00147	CcSEcCtD
Metolazone—CA9—HIF-1-alpha transcription factor network—CREB1—Alzheimer's disease	0.000258	0.00358	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000255	0.00354	CbGpPWpGaD
Metolazone—CA5A—Metabolism—DHCR24—Alzheimer's disease	0.000254	0.00352	CbGpPWpGaD
Metolazone—CA7—cerebellum—Alzheimer's disease	0.000249	0.0849	CbGeAlD
Metolazone—CA5B—Metabolism—DHCR24—Alzheimer's disease	0.000237	0.00328	CbGpPWpGaD
Metolazone—CA7—Metabolism—DHCR24—Alzheimer's disease	0.000237	0.00328	CbGpPWpGaD
Metolazone—CA12—Metabolism—DHCR24—Alzheimer's disease	0.000219	0.00304	CbGpPWpGaD
Metolazone—CA9—cerebellum—Alzheimer's disease	0.000219	0.0746	CbGeAlD
Metolazone—CA5A—Metabolism—CA4—Alzheimer's disease	0.000216	0.00299	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GAPDHS—Alzheimer's disease	0.000203	0.00281	CbGpPWpGaD
Metolazone—CA7—brain—Alzheimer's disease	0.000203	0.069	CbGeAlD
Metolazone—CA5B—Metabolism—CA4—Alzheimer's disease	0.000201	0.00279	CbGpPWpGaD
Metolazone—CA7—Metabolism—CA4—Alzheimer's disease	0.000201	0.00279	CbGpPWpGaD
Metolazone—CA4—forebrain—Alzheimer's disease	0.000196	0.0668	CbGeAlD
Metolazone—CA5A—Metabolism—ATP5A1—Alzheimer's disease	0.000192	0.00267	CbGpPWpGaD
Metolazone—CA7—Metabolism—GAPDHS—Alzheimer's disease	0.000189	0.00263	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GAPDHS—Alzheimer's disease	0.000189	0.00263	CbGpPWpGaD
Metolazone—CA12—Metabolism—CA4—Alzheimer's disease	0.000187	0.00259	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PLD3—Alzheimer's disease	0.000183	0.00254	CbGpPWpGaD
Metolazone—CA4—telencephalon—Alzheimer's disease	0.000181	0.0615	CbGeAlD
Metolazone—CA7—Metabolism—ATP5A1—Alzheimer's disease	0.00018	0.00249	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ATP5A1—Alzheimer's disease	0.00018	0.00249	CbGpPWpGaD
Metolazone—CA5A—Metabolism—HSD17B10—Alzheimer's disease	0.000176	0.00244	CbGpPWpGaD
Metolazone—CA12—Metabolism—GAPDHS—Alzheimer's disease	0.000175	0.00243	CbGpPWpGaD
Metolazone—CA4—Metabolism—DHCR24—Alzheimer's disease	0.000175	0.00243	CbGpPWpGaD
Metolazone—CA12—nervous system—Alzheimer's disease	0.000172	0.0586	CbGeAlD
Metolazone—CA5B—Metabolism—PLD3—Alzheimer's disease	0.000171	0.00237	CbGpPWpGaD
Metolazone—CA7—Metabolism—PLD3—Alzheimer's disease	0.000171	0.00237	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP46A1—Alzheimer's disease	0.000169	0.00235	CbGpPWpGaD
Metolazone—CA12—Metabolism—ATP5A1—Alzheimer's disease	0.000166	0.00231	CbGpPWpGaD
Metolazone—CA12—central nervous system—Alzheimer's disease	0.000166	0.0564	CbGeAlD
Metolazone—CA5B—Metabolism—HSD17B10—Alzheimer's disease	0.000164	0.00228	CbGpPWpGaD
Metolazone—CA7—Metabolism—HSD17B10—Alzheimer's disease	0.000164	0.00228	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ND1—Alzheimer's disease	0.000164	0.00227	CbGpPWpGaD
Metolazone—CA9—HIF-1-alpha transcription factor network—VEGFA—Alzheimer's disease	0.000162	0.00225	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.00016	0.00222	CbGpPWpGaD
Metolazone—CA12—Metabolism—PLD3—Alzheimer's disease	0.000159	0.0022	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP46A1—Alzheimer's disease	0.000158	0.00219	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP46A1—Alzheimer's disease	0.000158	0.00219	CbGpPWpGaD
Metolazone—CA5B—nervous system—Alzheimer's disease	0.000154	0.0526	CbGeAlD
Metolazone—CA7—Metabolism—ND1—Alzheimer's disease	0.000153	0.00212	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ND1—Alzheimer's disease	0.000153	0.00212	CbGpPWpGaD
Metolazone—CA12—Metabolism—HSD17B10—Alzheimer's disease	0.000152	0.00211	CbGpPWpGaD
Metolazone—CA5B—central nervous system—Alzheimer's disease	0.000149	0.0506	CbGeAlD
Metolazone—CA12—Metabolism—CYP46A1—Alzheimer's disease	0.000146	0.00203	CbGpPWpGaD
Metolazone—CA9—Metabolism—DHCR24—Alzheimer's disease	0.000141	0.00196	CbGpPWpGaD
Metolazone—CA12—Metabolism—ND1—Alzheimer's disease	0.000141	0.00196	CbGpPWpGaD
Metolazone—CA4—Metabolism—GAPDHS—Alzheimer's disease	0.00014	0.00194	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000136	0.00189	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—SOD1—Alzheimer's disease	0.000134	0.00186	CbGpPWpGaD
Metolazone—CA4—Metabolism—ATP5A1—Alzheimer's disease	0.000133	0.00184	CbGpPWpGaD
Metolazone—CA12—brain—Alzheimer's disease	0.000132	0.0448	CbGeAlD
Metolazone—CA4—Metabolism—PLD3—Alzheimer's disease	0.000127	0.00175	CbGpPWpGaD
Metolazone—CA4—Metabolism—HSD17B10—Alzheimer's disease	0.000121	0.00168	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—IL1A—Alzheimer's disease	0.000121	0.00168	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—SOD2—Alzheimer's disease	0.000121	0.00168	CbGpPWpGaD
Metolazone—CA9—Metabolism—CA4—Alzheimer's disease	0.00012	0.00167	CbGpPWpGaD
Metolazone—CA5B—brain—Alzheimer's disease	0.000118	0.0402	CbGeAlD
Metolazone—CA4—Metabolism—CYP46A1—Alzheimer's disease	0.000117	0.00162	CbGpPWpGaD
Metolazone—CA9—Metabolism—GAPDHS—Alzheimer's disease	0.000113	0.00157	CbGpPWpGaD
Metolazone—CA4—Metabolism—ND1—Alzheimer's disease	0.000113	0.00156	CbGpPWpGaD
Metolazone—CA9—Metabolism—ATP5A1—Alzheimer's disease	0.000107	0.00149	CbGpPWpGaD
Metolazone—CA4—nervous system—Alzheimer's disease	0.000107	0.0363	CbGeAlD
Metolazone—CA5A—Metabolism—CHAT—Alzheimer's disease	0.000105	0.00146	CbGpPWpGaD
Metolazone—CA5A—Metabolism—TPI1—Alzheimer's disease	0.000105	0.00146	CbGpPWpGaD
Metolazone—CA9—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	0.000103	0.00143	CbGpPWpGaD
Metolazone—CA4—central nervous system—Alzheimer's disease	0.000103	0.0349	CbGeAlD
Metolazone—CA9—Metabolism—PLD3—Alzheimer's disease	0.000102	0.00142	CbGpPWpGaD
Metolazone—CA5A—Metabolism—MAOB—Alzheimer's disease	0.000101	0.0014	CbGpPWpGaD
Metolazone—CA4—cerebellum—Alzheimer's disease	0.0001	0.0341	CbGeAlD
Metolazone—CA7—Metabolism—TPI1—Alzheimer's disease	9.84e-05	0.00136	CbGpPWpGaD
Metolazone—CA5B—Metabolism—TPI1—Alzheimer's disease	9.84e-05	0.00136	CbGpPWpGaD
Metolazone—CA7—Metabolism—CHAT—Alzheimer's disease	9.84e-05	0.00136	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CHAT—Alzheimer's disease	9.84e-05	0.00136	CbGpPWpGaD
Metolazone—CA9—Metabolism—HSD17B10—Alzheimer's disease	9.8e-05	0.00136	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GAPDH—Alzheimer's disease	9.73e-05	0.00135	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	9.53e-05	0.00132	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP46A1—Alzheimer's disease	9.44e-05	0.00131	CbGpPWpGaD
Metolazone—CA7—Metabolism—MAOB—Alzheimer's disease	9.43e-05	0.00131	CbGpPWpGaD
Metolazone—CA5B—Metabolism—MAOB—Alzheimer's disease	9.43e-05	0.00131	CbGpPWpGaD
Metolazone—CA5A—Metabolism—A2M—Alzheimer's disease	9.39e-05	0.0013	CbGpPWpGaD
Metolazone—CA9—Metabolism—ND1—Alzheimer's disease	9.11e-05	0.00126	CbGpPWpGaD
Metolazone—CA12—Metabolism—CHAT—Alzheimer's disease	9.11e-05	0.00126	CbGpPWpGaD
Metolazone—CA12—Metabolism—TPI1—Alzheimer's disease	9.11e-05	0.00126	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GAPDH—Alzheimer's disease	9.08e-05	0.00126	CbGpPWpGaD
Metolazone—CA7—Metabolism—GAPDH—Alzheimer's disease	9.08e-05	0.00126	CbGpPWpGaD
Metolazone—CA5B—Metabolism—A2M—Alzheimer's disease	8.77e-05	0.00122	CbGpPWpGaD
Metolazone—CA7—Metabolism—A2M—Alzheimer's disease	8.77e-05	0.00122	CbGpPWpGaD
Metolazone—CA12—Metabolism—MAOB—Alzheimer's disease	8.74e-05	0.00121	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—GSK3B—Alzheimer's disease	8.58e-05	0.00119	CbGpPWpGaD
Metolazone—CA12—Metabolism—GAPDH—Alzheimer's disease	8.41e-05	0.00117	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ACHE—Alzheimer's disease	8.17e-05	0.00113	CbGpPWpGaD
Metolazone—CA4—brain—Alzheimer's disease	8.15e-05	0.0277	CbGeAlD
Metolazone—CA12—Metabolism—A2M—Alzheimer's disease	8.12e-05	0.00113	CbGpPWpGaD
Metolazone—CA5A—Metabolism—INPP5D—Alzheimer's disease	8.08e-05	0.00112	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PTGS1—Alzheimer's disease	7.66e-05	0.00106	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ENO1—Alzheimer's disease	7.66e-05	0.00106	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ACHE—Alzheimer's disease	7.63e-05	0.00106	CbGpPWpGaD
Metolazone—CA7—Metabolism—ACHE—Alzheimer's disease	7.63e-05	0.00106	CbGpPWpGaD
Metolazone—CA7—Metabolism—INPP5D—Alzheimer's disease	7.54e-05	0.00105	CbGpPWpGaD
Metolazone—CA5B—Metabolism—INPP5D—Alzheimer's disease	7.54e-05	0.00105	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP2D6—Alzheimer's disease	7.51e-05	0.00104	CbGpPWpGaD
Metolazone—CA4—Metabolism—TPI1—Alzheimer's disease	7.27e-05	0.00101	CbGpPWpGaD
Metolazone—CA4—Metabolism—CHAT—Alzheimer's disease	7.27e-05	0.00101	CbGpPWpGaD
Metolazone—CA7—Metabolism—PTGS1—Alzheimer's disease	7.15e-05	0.000991	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PTGS1—Alzheimer's disease	7.15e-05	0.000991	CbGpPWpGaD
Metolazone—CA7—Metabolism—ENO1—Alzheimer's disease	7.15e-05	0.000991	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ENO1—Alzheimer's disease	7.15e-05	0.000991	CbGpPWpGaD
Metolazone—CA5A—Metabolism—BCHE—Alzheimer's disease	7.12e-05	0.000987	CbGpPWpGaD
Metolazone—CA12—Metabolism—ACHE—Alzheimer's disease	7.07e-05	0.00098	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP2D6—Alzheimer's disease	7.01e-05	0.000972	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP2D6—Alzheimer's disease	7.01e-05	0.000972	CbGpPWpGaD
Metolazone—CA12—Metabolism—INPP5D—Alzheimer's disease	6.99e-05	0.000968	CbGpPWpGaD
Metolazone—CA4—Metabolism—MAOB—Alzheimer's disease	6.97e-05	0.000966	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PLCB1—Alzheimer's disease	6.72e-05	0.000931	CbGpPWpGaD
Metolazone—CA4—Metabolism—GAPDH—Alzheimer's disease	6.71e-05	0.00093	CbGpPWpGaD
Metolazone—CA5B—Metabolism—BCHE—Alzheimer's disease	6.65e-05	0.000921	CbGpPWpGaD
Metolazone—CA7—Metabolism—BCHE—Alzheimer's disease	6.65e-05	0.000921	CbGpPWpGaD
Metolazone—CA12—Metabolism—PTGS1—Alzheimer's disease	6.62e-05	0.000918	CbGpPWpGaD
Metolazone—CA12—Metabolism—ENO1—Alzheimer's disease	6.62e-05	0.000918	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ABCA1—Alzheimer's disease	6.51e-05	0.000903	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP2D6—Alzheimer's disease	6.49e-05	0.0009	CbGpPWpGaD
Metolazone—CA4—Metabolism—A2M—Alzheimer's disease	6.48e-05	0.000898	CbGpPWpGaD
Metolazone—CA7—Metabolism—PLCB1—Alzheimer's disease	6.27e-05	0.000869	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PLCB1—Alzheimer's disease	6.27e-05	0.000869	CbGpPWpGaD
Metolazone—CA12—Metabolism—BCHE—Alzheimer's disease	6.16e-05	0.000854	CbGpPWpGaD
Metolazone—CA7—Metabolism—ABCA1—Alzheimer's disease	6.08e-05	0.000843	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ABCA1—Alzheimer's disease	6.08e-05	0.000843	CbGpPWpGaD
Metolazone—CA9—Metabolism—TPI1—Alzheimer's disease	5.87e-05	0.000814	CbGpPWpGaD
Metolazone—CA9—Metabolism—CHAT—Alzheimer's disease	5.87e-05	0.000814	CbGpPWpGaD
Metolazone—CA12—Metabolism—PLCB1—Alzheimer's disease	5.81e-05	0.000805	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—MAPK8—Alzheimer's disease	5.79e-05	0.000803	CbGpPWpGaD
Metolazone—CA4—Metabolism—ACHE—Alzheimer's disease	5.64e-05	0.000781	CbGpPWpGaD
Metolazone—CA9—Metabolism—MAOB—Alzheimer's disease	5.63e-05	0.000781	CbGpPWpGaD
Metolazone—CA12—Metabolism—ABCA1—Alzheimer's disease	5.63e-05	0.000781	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PPARGC1A—Alzheimer's disease	5.61e-05	0.000778	CbGpPWpGaD
Metolazone—CA5A—Metabolism—HMOX1—Alzheimer's disease	5.59e-05	0.000774	CbGpPWpGaD
Metolazone—CA4—Metabolism—INPP5D—Alzheimer's disease	5.57e-05	0.000772	CbGpPWpGaD
Metolazone—CA9—Metabolism—GAPDH—Alzheimer's disease	5.42e-05	0.000751	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—VEGFA—Alzheimer's disease	5.35e-05	0.000741	CbGpPWpGaD
Metolazone—CA4—Metabolism—PTGS1—Alzheimer's disease	5.28e-05	0.000732	CbGpPWpGaD
Metolazone—CA4—Metabolism—ENO1—Alzheimer's disease	5.28e-05	0.000732	CbGpPWpGaD
Metolazone—CA7—Metabolism—PPARGC1A—Alzheimer's disease	5.24e-05	0.000726	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PPARGC1A—Alzheimer's disease	5.24e-05	0.000726	CbGpPWpGaD
Metolazone—CA9—Metabolism—A2M—Alzheimer's disease	5.23e-05	0.000726	CbGpPWpGaD
Metolazone—CA5B—Metabolism—HMOX1—Alzheimer's disease	5.21e-05	0.000723	CbGpPWpGaD
Metolazone—CA7—Metabolism—HMOX1—Alzheimer's disease	5.21e-05	0.000723	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP2D6—Alzheimer's disease	5.18e-05	0.000718	CbGpPWpGaD
Metolazone—CA5A—Metabolism—LPL—Alzheimer's disease	5.11e-05	0.000708	CbGpPWpGaD
Metolazone—CA4—Metabolism—BCHE—Alzheimer's disease	4.91e-05	0.000681	CbGpPWpGaD
Metolazone—CA12—Metabolism—PPARGC1A—Alzheimer's disease	4.85e-05	0.000673	CbGpPWpGaD
Metolazone—CA12—Metabolism—HMOX1—Alzheimer's disease	4.83e-05	0.00067	CbGpPWpGaD
Metolazone—CA5B—Metabolism—LPL—Alzheimer's disease	4.77e-05	0.000661	CbGpPWpGaD
Metolazone—CA7—Metabolism—LPL—Alzheimer's disease	4.77e-05	0.000661	CbGpPWpGaD
Metolazone—CA4—Metabolism—PLCB1—Alzheimer's disease	4.63e-05	0.000642	CbGpPWpGaD
Metolazone—CA5A—Metabolism—MTHFR—Alzheimer's disease	4.6e-05	0.000638	CbGpPWpGaD
Metolazone—CA9—Metabolism—ACHE—Alzheimer's disease	4.55e-05	0.000631	CbGpPWpGaD
Metolazone—CA9—Metabolism—INPP5D—Alzheimer's disease	4.5e-05	0.000624	CbGpPWpGaD
Metolazone—CA4—Metabolism—ABCA1—Alzheimer's disease	4.49e-05	0.000623	CbGpPWpGaD
Metolazone—CA12—Metabolism—LPL—Alzheimer's disease	4.42e-05	0.000613	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CALM1—Alzheimer's disease	4.3e-05	0.000596	CbGpPWpGaD
Metolazone—CA7—Metabolism—MTHFR—Alzheimer's disease	4.29e-05	0.000595	CbGpPWpGaD
Metolazone—CA5B—Metabolism—MTHFR—Alzheimer's disease	4.29e-05	0.000595	CbGpPWpGaD
Metolazone—CA5A—Metabolism—APOE—Alzheimer's disease	4.28e-05	0.000594	CbGpPWpGaD
Metolazone—CA9—Metabolism—ENO1—Alzheimer's disease	4.27e-05	0.000592	CbGpPWpGaD
Metolazone—CA9—Metabolism—PTGS1—Alzheimer's disease	4.27e-05	0.000592	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CAV1—Alzheimer's disease	4.24e-05	0.000588	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP2D6—Alzheimer's disease	4.19e-05	0.00058	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—TP53—Alzheimer's disease	4.04e-05	0.00056	CbGpPWpGaD
Metolazone—CA7—Metabolism—CALM1—Alzheimer's disease	4.01e-05	0.000556	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CALM1—Alzheimer's disease	4.01e-05	0.000556	CbGpPWpGaD
Metolazone—CA7—Metabolism—APOE—Alzheimer's disease	4e-05	0.000554	CbGpPWpGaD
Metolazone—CA5B—Metabolism—APOE—Alzheimer's disease	4e-05	0.000554	CbGpPWpGaD
Metolazone—CA12—Metabolism—MTHFR—Alzheimer's disease	3.98e-05	0.000552	CbGpPWpGaD
Metolazone—CA9—Metabolism—BCHE—Alzheimer's disease	3.97e-05	0.00055	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CAV1—Alzheimer's disease	3.96e-05	0.000549	CbGpPWpGaD
Metolazone—CA7—Metabolism—CAV1—Alzheimer's disease	3.96e-05	0.000549	CbGpPWpGaD
Metolazone—CA4—Metabolism—PPARGC1A—Alzheimer's disease	3.87e-05	0.000537	CbGpPWpGaD
Metolazone—CA4—Metabolism—HMOX1—Alzheimer's disease	3.85e-05	0.000534	CbGpPWpGaD
Metolazone—CA9—Metabolism—PLCB1—Alzheimer's disease	3.74e-05	0.000519	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PPARG—Alzheimer's disease	3.73e-05	0.000517	CbGpPWpGaD
Metolazone—CA12—Metabolism—CALM1—Alzheimer's disease	3.72e-05	0.000515	CbGpPWpGaD
Metolazone—CA12—Metabolism—APOE—Alzheimer's disease	3.7e-05	0.000513	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—IL6—Alzheimer's disease	3.7e-05	0.000513	CbGpPWpGaD
Metolazone—CA12—Metabolism—CAV1—Alzheimer's disease	3.67e-05	0.000509	CbGpPWpGaD
Metolazone—CA5A—Metabolism—INS—Alzheimer's disease	3.66e-05	0.000507	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCA1—Alzheimer's disease	3.63e-05	0.000503	CbGpPWpGaD
Metolazone—CA4—Metabolism—LPL—Alzheimer's disease	3.52e-05	0.000488	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PPARG—Alzheimer's disease	3.48e-05	0.000483	CbGpPWpGaD
Metolazone—CA7—Metabolism—PPARG—Alzheimer's disease	3.48e-05	0.000483	CbGpPWpGaD
Metolazone—CA5B—Metabolism—INS—Alzheimer's disease	3.42e-05	0.000473	CbGpPWpGaD
Metolazone—CA7—Metabolism—INS—Alzheimer's disease	3.42e-05	0.000473	CbGpPWpGaD
Metolazone—CA12—Metabolism—PPARG—Alzheimer's disease	3.23e-05	0.000447	CbGpPWpGaD
Metolazone—CA5A—Metabolism—NOS3—Alzheimer's disease	3.21e-05	0.000445	CbGpPWpGaD
Metolazone—CA4—Metabolism—MTHFR—Alzheimer's disease	3.17e-05	0.00044	CbGpPWpGaD
Metolazone—CA12—Metabolism—INS—Alzheimer's disease	3.16e-05	0.000439	CbGpPWpGaD
Metolazone—CA9—Metabolism—PPARGC1A—Alzheimer's disease	3.13e-05	0.000434	CbGpPWpGaD
Metolazone—CA9—Metabolism—HMOX1—Alzheimer's disease	3.11e-05	0.000432	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NOS3—Alzheimer's disease	3e-05	0.000415	CbGpPWpGaD
Metolazone—CA7—Metabolism—NOS3—Alzheimer's disease	3e-05	0.000415	CbGpPWpGaD
Metolazone—CA4—Metabolism—CALM1—Alzheimer's disease	2.96e-05	0.000411	CbGpPWpGaD
Metolazone—CA4—Metabolism—APOE—Alzheimer's disease	2.95e-05	0.000409	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PTGS2—Alzheimer's disease	2.93e-05	0.000407	CbGpPWpGaD
Metolazone—CA4—Metabolism—CAV1—Alzheimer's disease	2.93e-05	0.000406	CbGpPWpGaD
Metolazone—CA9—Metabolism—LPL—Alzheimer's disease	2.85e-05	0.000395	CbGpPWpGaD
Metolazone—CA12—Metabolism—NOS3—Alzheimer's disease	2.77e-05	0.000385	CbGpPWpGaD
Metolazone—CA7—Metabolism—PTGS2—Alzheimer's disease	2.74e-05	0.00038	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PTGS2—Alzheimer's disease	2.74e-05	0.00038	CbGpPWpGaD
Metolazone—CA4—Metabolism—PPARG—Alzheimer's disease	2.57e-05	0.000357	CbGpPWpGaD
Metolazone—CA9—Metabolism—MTHFR—Alzheimer's disease	2.56e-05	0.000355	CbGpPWpGaD
Metolazone—CA12—Metabolism—PTGS2—Alzheimer's disease	2.54e-05	0.000352	CbGpPWpGaD
Metolazone—CA4—Metabolism—INS—Alzheimer's disease	2.52e-05	0.00035	CbGpPWpGaD
Metolazone—CA9—Metabolism—CALM1—Alzheimer's disease	2.4e-05	0.000332	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOE—Alzheimer's disease	2.39e-05	0.000331	CbGpPWpGaD
Metolazone—CA9—Metabolism—CAV1—Alzheimer's disease	2.36e-05	0.000328	CbGpPWpGaD
Metolazone—CA4—Metabolism—NOS3—Alzheimer's disease	2.21e-05	0.000307	CbGpPWpGaD
Metolazone—CA9—Metabolism—PPARG—Alzheimer's disease	2.08e-05	0.000288	CbGpPWpGaD
Metolazone—CA9—Metabolism—INS—Alzheimer's disease	2.04e-05	0.000283	CbGpPWpGaD
Metolazone—CA4—Metabolism—PTGS2—Alzheimer's disease	2.02e-05	0.000281	CbGpPWpGaD
Metolazone—CA9—Metabolism—NOS3—Alzheimer's disease	1.79e-05	0.000248	CbGpPWpGaD
Metolazone—CA9—Metabolism—PTGS2—Alzheimer's disease	1.64e-05	0.000227	CbGpPWpGaD
Metolazone—CA5A—Metabolism—AKT1—Alzheimer's disease	1.47e-05	0.000204	CbGpPWpGaD
Metolazone—CA7—Metabolism—AKT1—Alzheimer's disease	1.38e-05	0.000191	CbGpPWpGaD
Metolazone—CA5B—Metabolism—AKT1—Alzheimer's disease	1.38e-05	0.000191	CbGpPWpGaD
Metolazone—CA12—Metabolism—AKT1—Alzheimer's disease	1.28e-05	0.000177	CbGpPWpGaD
Metolazone—CA4—Metabolism—AKT1—Alzheimer's disease	1.02e-05	0.000141	CbGpPWpGaD
Metolazone—CA9—Metabolism—AKT1—Alzheimer's disease	8.22e-06	0.000114	CbGpPWpGaD
